InvestorsHub Logo

H2R

Followers 42
Posts 2161
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: H2R post# 3007

Monday, 06/12/2017 7:08:56 PM

Monday, June 12, 2017 7:08:56 PM

Post# of 3271
The Achilles heel for WINT (as for some other small cap clinical stage company) was the balance sheet weakness. This should reassure investors that the Company is not going under.

My guess is that it will have a positive impact on the PPS!

Cheers!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent WINT News